Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial

Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Updated the disease terminology from 'Mucopolysaccharidosis type 4A' to 'Mucopolysaccharidosis, MPS-IV-A' across the study page.
    Difference
    0.1%
    Check dated 2026-03-26T11:43:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    - Site revision updated from v3.4.3 to v3.5.0. - No visible changes to study content or layout.
    Difference
    0.1%
    Check dated 2026-03-19T05:29:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:57:48.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding notice and Revision: v3.4.1 text; these are administrative changes that do not affect the study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:27:40.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and current operations was added, directing users to cc.nih.gov and opm.gov, and the page version was updated from 3.4.0 to 3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:18:59.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Additions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These updates are administrative and do not affect study data or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:13:48.000Z thumbnail image

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.